Resultados de la búsqueda 61-70 of 2911 for free t3
... free survival (PFS) rate as compared to ACNS0122. Also, to improve disease ... free survival, as compared to doxorubicin alone (Arm 1). Anti-cancer ...
... free of reoperation, and to define characteristics and comorbidities of patients undergoing unilateral and bilateral MUA. Extracellular Impact Of Ultrasound ...
... free from post-operative cerebrospinal fluid (CSF) leaks. Additional safety outcomes (i.e., surgical site infections and adverse events/device-related ...
... free of reoperation, and to define characteristics and comorbidities of patients undergoing unilateral and bilateral MUA. Cognitive Advancement and Recovery ...
... free of reoperation, and to define characteristics and comorbidities of patients undergoing unilateral and bilateral MUA. MElanoma Research Lymph node ...
... free survival, as compared to doxorubicin alone (Arm 1). Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. A ...
The rationale for using MUC1-stimulated T-cells to treat multiple myeloma is twofold. The first is that T-cell therapies have been shown to be active in myeloma ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?